Physicians’ Education Resource® Presents ‘Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in Trials’ Symposium

The symposium will be held during the American Association for Cancer Research Annual Meeting

CRANBURY, N.J.--()--Physicians’ Education Resource® (PER®), the leading resource for hematology and oncology continuing medical education, presents “Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in Trials” live symposium during the American Association for Cancer Research (AACR) annual meeting. The event will take place on April 16 at the Chicago Hyatt Regency in Crystal Ballroom at 6:30 p.m.

“Given the rapid developments in using targeted therapies in treating lung cancer, we are very excited to feature this symposium at the AACR annual meeting to share the latest data, interpret the trial results, and help drive better patient outcomes in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancers,” said Phil Talamo, president PER®.

Designed for medical oncologists and cancer researchers, this symposium offers a maximum of 2.0 American Medical Association Physician’s recognition Award Category 1 Credits™. The event will delve into discussions on the new standards of care for the first-line therapy of patients with EGFR mutation-positive NSCLC, the changing landscape for subsequent lines of therapy and incorporating liquid-based and tissue-based molecular testing to optimize therapeutic decision making. The symposium will also review tumor-testing strategies, management of patients with central nervous system involvement and the impact of treatment-related toxicities.

For more information and to register, visit http://www.gotoper.com/conferences/aacr18egfr/meetings/practical-application-of-sequencing-for-egfr-mutant-lung-cancers-a-focus-on-recent-evidence-and-key-next-steps-in-trials.

About PER®:

Since 1995, Physicians’ Education Resource, LLC® (PER®), has been the leading provider of live and online continuing medical education activities on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2018, PER® will develop and implement 20 historic annual legacy conferences in the United States and Europe, along with many world-renowned online learning formats, such as Medical Crossfire®. PER is accredited by both the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.

Contacts

PER® Media Contacts:
Theresa Burek, 609-325-4811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com

Release Summary

PER® Presents ‘Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in Trials’ Symposium

Contacts

PER® Media Contacts:
Theresa Burek, 609-325-4811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com